Yuan Y - Search Results

1

Sorafenib therapy following resection prolongs disease-free survival in patients with advanced hepatocellular carcinoma at a high risk of recurrence.

Liao Y, Zheng Y, He W, Li Q, Shen J, Hong J, Zou R, Qiu J, Li B, Yuan Y. Liao Y, et al. Among authors: yuan y. Oncol Lett. 2017 Feb;13(2):984-992. doi: 10.3892/ol.2016.5525. Epub 2016 Dec 20. Oncol Lett. 2017. PMID: 28356989 Free PMC article.

2

[Long-term prognosis after hepatic resection for huge primary liver cancer].

Yuan YF, Li BK, Li JQ, Zhang YQ, Guo RP, Lin XJ, Li GH. Yuan YF, et al. Ai Zheng. 2004 Jul;23(7):821-4. Ai Zheng. 2004. PMID: 15248920 Chinese.

3

[Evaluation of new TNM staging system for hepatocellular carcinoma after hepatectomy].

Li BK, Cui BK, Yuan YF, Li JQ, Zhang YQ, Shi M, Li GH. Li BK, et al. Ai Zheng. 2005 Jul;24(7):769-73. Ai Zheng. 2005. PMID: 16004798 Chinese.

4

[Clinical analysis of 38 cases of hepatic focal nodular hyperplasia and literature review].

Huang J, Li BK, Yuan YF, Cui BK, Li JQ, Zhang YQ, Li GH. Huang J, et al. Ai Zheng. 2005 Oct;24(10):1241-5. Ai Zheng. 2005. PMID: 16219140 Review. Chinese.

5

[Surgical treatment for hepatocellular carcinoma patients with severe cirrhosis--a report of 67 cases].

Hong J, Yuan YF, Li BK, Huang L, Li JQ, Zhang YQ, Li GH. Hong J, et al. Ai Zheng. 2007 Jun;26(6):620-3. Ai Zheng. 2007. PMID: 17562268 Free article. Chinese.

6

[Acute toxicity of carbon-coated iron nanocrystal and its effect on liver and kidney functions and hematological system].

Lao XM, Zhang HY, Li JQ, Chen YM, Chen MS, Yuan YF, Zhang YQ, Zheng Y. Lao XM, et al. Among authors: yuan yf. Nan Fang Yi Ke Da Xue Xue Bao. 2007 Oct;27(10):1471-5. Nan Fang Yi Ke Da Xue Xue Bao. 2007. PMID: 17959516 Chinese.

7

[Effects of carbon-coated iron nanocrystals combined with epirubicin on HepG-2 cells and its acute toxicity in mice].

Zheng Y, Lao XM, Zhang HY, Chen YM, Chen MS, Yuan YF, Zhang YQ, Li JQ. Zheng Y, et al. Among authors: yuan yf. Nan Fang Yi Ke Da Xue Xue Bao. 2008 Feb;28(2):176-9. Nan Fang Yi Ke Da Xue Xue Bao. 2008. PMID: 18250036 Chinese.

8

Clinicopathologic features and long-term outcomes of Chinese patients with hepatocellular carcinoma in non-cirrhotic liver.

Xu L, Huang L, Li BK, Zhang YQ, Li JQ, Yuan YF. Xu L, et al. Dig Surg. 2008;25(5):376-82. doi: 10.1159/000170881. Epub 2008 Nov 13. Dig Surg. 2008. PMID: 19005256

9

Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy.

Huang J, Li BK, Chen GH, Li JQ, Zhang YQ, Li GH, Yuan YF. Huang J, et al. J Gastrointest Surg. 2009 Sep;13(9):1627-35. doi: 10.1007/s11605-009-0933-4. Epub 2009 Jun 9. J Gastrointest Surg. 2009. PMID: 19506976

10

[Clinical observation of sorafenib monotherapy in Chinese patients with advanced hepatocellular carcinoma].

Xu L, Li P, Lin XJ, Yuan YF, Zhang YQ, Chen MS. Xu L, et al. Zhonghua Zhong Liu Za Zhi. 2009 Jan;31(1):58-61. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19538872 Clinical Trial. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,683 results

Search Page

Filters